DK3411389T3 - Nye streptokokproteaser - Google Patents
Nye streptokokproteaser Download PDFInfo
- Publication number
- DK3411389T3 DK3411389T3 DK17703958.3T DK17703958T DK3411389T3 DK 3411389 T3 DK3411389 T3 DK 3411389T3 DK 17703958 T DK17703958 T DK 17703958T DK 3411389 T3 DK3411389 T3 DK 3411389T3
- Authority
- DK
- Denmark
- Prior art keywords
- proteases
- new
- new streptococcal
- streptococcal proteases
- streptococcal
- Prior art date
Links
- 102000035195 Peptidases Human genes 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
- C12N9/641—Cysteine endopeptidases (3.4.22)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Bioinformatics & Computational Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1630021 | 2016-02-04 | ||
| PCT/EP2017/052463 WO2017134274A1 (en) | 2016-02-04 | 2017-02-03 | New streptococcal proteases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3411389T3 true DK3411389T3 (da) | 2021-06-21 |
Family
ID=57995190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17703958.3T DK3411389T3 (da) | 2016-02-04 | 2017-02-03 | Nye streptokokproteaser |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12006530B2 (enExample) |
| EP (1) | EP3411389B1 (enExample) |
| JP (2) | JP7123801B2 (enExample) |
| KR (1) | KR102704583B1 (enExample) |
| CN (1) | CN109311951B (enExample) |
| AU (1) | AU2017214441B2 (enExample) |
| CA (1) | CA3013527C (enExample) |
| DK (1) | DK3411389T3 (enExample) |
| ES (1) | ES2877754T3 (enExample) |
| PL (1) | PL3411389T3 (enExample) |
| PT (1) | PT3411389T (enExample) |
| SG (1) | SG11201806639VA (enExample) |
| WO (1) | WO2017134274A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016023046A8 (pt) | 2014-04-04 | 2021-05-11 | Mayo Found Medical Education & Res | kit compreendendo anticorpos e agentes redutores |
| WO2017053932A1 (en) | 2015-09-24 | 2017-03-30 | Mayo Foundation For Medical Education And Research | Identification of immunoglobulin free light chains by mass spectrometry |
| SG11201806639VA (en) | 2016-02-04 | 2018-09-27 | Genovis Ab | New streptococcal proteases |
| EP3523647B1 (en) | 2016-09-07 | 2024-06-26 | Mayo Foundation for Medical Education and Research | Identification and monitoring of cleaved immunoglobulins by molecular mass |
| FI3630968T3 (fi) | 2017-05-26 | 2024-07-24 | Genovis Ab | Entsyymejä glykaanien analysointiin |
| US20210228738A1 (en) | 2017-07-17 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
| WO2019055634A1 (en) | 2017-09-13 | 2019-03-21 | Mayo Foundation For Medical Education And Research | IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR |
| EP3681907A4 (en) | 2017-09-13 | 2021-07-07 | Mayo Foundation for Medical Education and Research | IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN J-CHAINS |
| JP7425728B2 (ja) | 2017-12-15 | 2024-01-31 | インターベット インターナショナル ベー． フェー． | レンサ球菌感染防御のためのワクチン |
| JP2022550435A (ja) | 2019-10-04 | 2022-12-01 | ウルトラジェニックス ファーマシューティカル インコーポレイテッド | 組換えａａｖの改善された治療的使用のための方法 |
| MX2022009982A (es) | 2020-02-14 | 2022-09-12 | Ultragenyx Pharmaceutical Inc | Terapia genica para el tratamiento de transtorno por deficiencia de cdkl5. |
| GB202002072D0 (en) * | 2020-02-14 | 2020-04-01 | Hansa Biopharma AB | immunoglobulin detection and associated therapies |
| JP2023532219A (ja) * | 2020-06-18 | 2023-07-27 | 上海宝済薬業有限公司 | 免疫グロブリン分解酵素ＩｄｅＥの突然変異体 |
| JP2023545731A (ja) | 2020-10-07 | 2023-10-31 | アスクレピオス バイオファーマシューティカル， インコーポレイテッド | 肢帯型２ｉ（ｌｇｍｄ２ｉ）を含むジストログリカノパチー障害を処置するためのフクチン関連タンパク質（ｆｋｒｐ）の治療的アデノ随伴ウイルス送達 |
| JP2024515626A (ja) | 2021-04-16 | 2024-04-10 | アスクレピオス バイオファーマシューティカル， インコーポレイテッド | 血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドａａｖビリオン |
| EP4079848A1 (en) | 2021-04-22 | 2022-10-26 | Genovis Ab | Immunoglobulin cleaving enzyme |
| WO2022266044A1 (en) * | 2021-06-15 | 2022-12-22 | The University Of North Carolina At Chapel Hill | Methods and compositions for depleting antibodies |
| US20250019721A1 (en) | 2021-08-11 | 2025-01-16 | Ultragenyx Pharmaceutical Inc. | Compositions and methods for treating a muscular dystrophy |
| EP4433079A1 (en) * | 2021-11-18 | 2024-09-25 | Intervet International B.V. | A method to produce a vaccine against streptococcus suis and the said vaccine |
| AR131163A1 (es) * | 2022-11-25 | 2025-02-19 | Chugai Pharmaceutical Co Ltd | Métodos para producir proteínas |
| WO2025047641A1 (ja) * | 2023-08-25 | 2025-03-06 | 積水メディカル株式会社 | 免疫学的測定方法、免疫学的測定用試薬、免疫学的測定用検体前処理液、及び免疫学的測定用試薬キット、非特異反応抑制剤 |
| WO2025256977A1 (en) | 2024-06-13 | 2025-12-18 | Bayer Aktiengesellschaft | Novel igm and igg cleaving enzymes |
| WO2025256978A1 (en) | 2024-06-13 | 2025-12-18 | Bayer Aktiengesellschaft | Variants of igm and igg cleaving enzymes |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2824074A1 (fr) * | 2001-04-26 | 2002-10-31 | Pasteur Institut | Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques |
| GB0130228D0 (en) | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
| WO2006069200A2 (en) | 2004-12-22 | 2006-06-29 | Novartis Vaccines And Diagnostics Inc. | Group b streptococcus |
| ATE548049T1 (de) | 2005-06-09 | 2012-03-15 | Hansa Medical Ab | Verwendung von ides proteinase (von s. pyogenes) zur behandlung von autoimmunkrankheiten und transplantatabstossung |
| CN101889082A (zh) | 2007-09-14 | 2010-11-17 | 季诺维斯公司 | 用于解离Fcgamma-受体-IgG复合物以及纯化与检测IgG的方法和试剂盒 |
| GB201115841D0 (en) * | 2011-09-13 | 2011-10-26 | Genovis Ab | Protein and method |
| GB201316744D0 (en) * | 2013-09-20 | 2013-11-06 | Genovis Ab | Method |
| SG11201806639VA (en) | 2016-02-04 | 2018-09-27 | Genovis Ab | New streptococcal proteases |
-
2017
- 2017-02-03 SG SG11201806639VA patent/SG11201806639VA/en unknown
- 2017-02-03 PT PT177039583T patent/PT3411389T/pt unknown
- 2017-02-03 CA CA3013527A patent/CA3013527C/en active Active
- 2017-02-03 ES ES17703958T patent/ES2877754T3/es active Active
- 2017-02-03 DK DK17703958.3T patent/DK3411389T3/da active
- 2017-02-03 US US16/075,059 patent/US12006530B2/en active Active
- 2017-02-03 PL PL17703958T patent/PL3411389T3/pl unknown
- 2017-02-03 WO PCT/EP2017/052463 patent/WO2017134274A1/en not_active Ceased
- 2017-02-03 CN CN201780022485.6A patent/CN109311951B/zh active Active
- 2017-02-03 JP JP2018540841A patent/JP7123801B2/ja active Active
- 2017-02-03 AU AU2017214441A patent/AU2017214441B2/en active Active
- 2017-02-03 KR KR1020187025476A patent/KR102704583B1/ko active Active
- 2017-02-03 EP EP17703958.3A patent/EP3411389B1/en active Active
-
2022
- 2022-03-30 JP JP2022056522A patent/JP2022115853A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| KR102704583B1 (ko) | 2024-09-06 |
| CA3013527A1 (en) | 2017-08-10 |
| SG11201806639VA (en) | 2018-09-27 |
| EP3411389B1 (en) | 2021-03-24 |
| PL3411389T3 (pl) | 2021-10-25 |
| AU2017214441A1 (en) | 2018-08-16 |
| AU2017214441B2 (en) | 2021-08-19 |
| PT3411389T (pt) | 2021-06-28 |
| JP2022115853A (ja) | 2022-08-09 |
| KR20180124857A (ko) | 2018-11-21 |
| WO2017134274A1 (en) | 2017-08-10 |
| US20190345533A1 (en) | 2019-11-14 |
| CN109311951B (zh) | 2022-10-11 |
| JP7123801B2 (ja) | 2022-08-23 |
| US12006530B2 (en) | 2024-06-11 |
| CN109311951A (zh) | 2019-02-05 |
| ES2877754T3 (es) | 2021-11-17 |
| EP3411389A1 (en) | 2018-12-12 |
| CA3013527C (en) | 2023-09-05 |
| JP2019506866A (ja) | 2019-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3411389T3 (da) | Nye streptokokproteaser | |
| DK3212780T3 (da) | Serinprotease | |
| LT3256580T (lt) | Cisteino proteazė | |
| DK3212662T3 (da) | Serinproteaser | |
| EP3403854A4 (en) | TIRE | |
| EP3403853A4 (en) | TIRE | |
| EP3466720A4 (en) | TIRE | |
| EP3466719A4 (en) | TIRE | |
| DK3212781T3 (da) | Serinproteaser | |
| EP3508358A4 (en) | TIRE | |
| EP3466722A4 (en) | TIRE | |
| DK3679133T3 (da) | Ydelsesforbedrede proteasevarianter | |
| EP3437900A4 (en) | TIRE | |
| EP3418613A4 (en) | ELECTRIC VALVE | |
| EP3459763A4 (en) | TIRE | |
| DK3193930T3 (da) | Nye polypeptider | |
| EP3508359A4 (en) | TIRE | |
| EP3446886A4 (en) | TIRE | |
| EP3418074A4 (en) | TIRE | |
| EP3406461A4 (en) | TIRE | |
| DK3298022T3 (da) | Nye annelerede phenoxyacetamider | |
| EP3538665C0 (en) | PROTEASE DETECTION MOLECULES | |
| EP3498493A4 (en) | TIRE | |
| DK3097084T3 (da) | Nye kallikrein 7-hæmmere | |
| EP3550018A4 (en) | NEW ENDO-SS-N-ACETYLGLUCOSAMINIDASE |